NCT04442022
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04442022
Title A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or Without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | ISR | ESP

Facility Status City State Zip Country Details
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler Arizona 85224 United States Details
Arizona Oncology Associates Tucson Arizona 85711 United States Details
The Oncology Institute (TOI) Clinical Research Cerritos California 90703 United States Details
Norton Cancer Institute, St. Matthews Louisville Kentucky 40207 United States Details
University of Maryland Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Stony Brook Stony Brook New York 11794 United States Details
Texas Oncology - Tyler Tyler Texas 75702 United States Details
The University of Texas Health Science Center at Tyler DBA UT Health East Texas HOPE Cancer Center Tyler Texas 75702 United States Details
Jiangsu Province Hospital Nanjing Jiangsu 210029 China Details
The First Affiliated Hospital of Soochow University Suzhou Jiangsu 215006 China Details
Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School Huangpu Shanghai Municipality 200025 China Details
Zhongshan Hospital Fudan University Xuhui Shanghai Municipality 200032 China Details
Huaxi Hospital Sichuan University Chengdu Sichuan 610044 China Details
The first affiliated Hospital, Zhejiang University Hangzhou Zhejiang 310003 China Details
Assuta Ashdod Medical Center Ashdod 7747629 Israel Details
Soroka Medical Center Beersheba 8457108 Israel Details
Rabin Medical Center Petah Tikva 4941492 Israel Details
Assuta medical centers - Ramat Hachayal Tel Aviv 6423906 Israel Details
AOU Ospedali Riuniti-Università Politecnica delle Marche Clinica di Ematologia Ancona Ancona 60020 Italy Details
UOC Ematologia ad Indirizzo Oncologico, AORN "Sant'Anna e San Sebastiano" Caserta Caserta 81100 Italy Details
National Cancer Institute Naples Napoli 1-80131 Italy Details
AOU Maggiore della Carità SCDU Ematologia Novara Novara 28100 Italy Details
DIP. Oncologia- Ematologia, UOSD Centro Diagnosie TerapiaDei Linfomi Pescara Pescara 65124 Italy Details
Fondatione Policlinico Universitario A. Gemelli Rome Rome 00168 Italy Details
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello Palermo Sicily 90146 Italy Details
AOU City of Health and Science of Turin Turin Torino 10126 Italy Details
Pratia MCM Krakow Krakow Lesser 30-510 Poland Details
Szpitale pomorskie gdynia dept of haematology Gdynia Pomeranian Voivodeship 81-519 Poland Details
Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku Uniwersytecki Szpital Kliniczny im. Jana Mikulicza - Radeckiego we Wrocławiu Wroclaw Radeckiego 50-367 Poland Details
Pratia Onkologia Katowice Katowice Silesian Voivodeship 40-523 Poland Details
CM Pratia Poznań Skorzewo Wielkopolska 60819 Poland Details
Institute of Hematology and Transfusion Medicine Warsaw 00-791 Poland Details
Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw 02-781 Poland Details
Institut català d'oncologia-hospital germans trias i pujol Badalona Barcelona 08916 Spain Details
Hospital Vall Hebron Barcelona Barcelona 08035 Spain Details
Institut Catala D'oncolocia Barcelona Barcelona 09809 Spain Details
Hospital Universitario La Paz Madrid Madrid 28046 Spain Details
Hospital Virgen del Rocío Seville Seville 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field